The pyrazinamide susceptibility breakpoint above which combination therapy fails

OBJECTIVES: To identify the pyrazinamide MIC above which standard combination therapy fails. METHODS: MICs of pyrazinamide were determined for Mycobacterium tuberculosis isolates, cultured from 58 patients in a previous randomized clinical trial in Cape Town, South Africa. The MICs were determined u...

Descripción completa

Detalles Bibliográficos
Autores principales: Gumbo, Tawanda, Chigutsa, Emmanuel, Pasipanodya, Jotam, Visser, Marianne, van Helden, Paul D., Sirgel, Frederick A, McIlleron, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130380/
https://www.ncbi.nlm.nih.gov/pubmed/24821594
http://dx.doi.org/10.1093/jac/dku136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130380/
https://www.ncbi.nlm.nih.gov/pubmed/24821594
http://dx.doi.org/10.1093/jac/dku136

Ejemplares similares